Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

a less useful outcome-based KPI for pharma than for other industries." High performing sales organisations operationalise their call coverage models off a clearly defined plan that begins with ...

In the past 10 years, commercial practices within pharmaceutical sales have moved from sales force ... "If you have a call plan, you visit the doctor, you deliver the message and report it back.

Verona Pharma plc (VRNA), a biopharmaceutical company, Tuesday announced that the company expects preliminary unaudited fourth ...

Hepion Pharmaceuticals and Pharma Two B have terminated a reverse merger agreement that was expected to close by the end of the year. The decision was mutual, meaning neither company will have to ...

As part of the agreement, McKinsey admitted in a court filing that it chose to continue working with Purdue Pharma to improve sales of OxyContin despite knowing the risks of the addictive opioid.

The latest announcement is out from Solasia Pharma KK ( (JP:4597) ).

Guidance Cut Ascendis Pharma reported lower-than-expected Q2 2024 sales of $38.76 million, missing the consensus estimate of $92.7 million due to a significant adjustment to prior sales estimates.